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Abstract In the field of inhalation toxicology, progress in
the development of in vitro methods and efficient exposure
strategies now offers the implementation of cellular-based
systems. These can be used to analyze the hazardous
potency of airborne substances like gases, particles, and
complex mixtures (combustion products). In addition, the
regulatory authorities require the integration of such
approaches to reduce or replace animal experiments. Al-
thoughthe animalexperimentcurrently still has toprovide the
last proof of the toxicological potency and classification of a
certain compound, in vitro testing is gaining more and more
importance in toxicological considerations. This paper gives a
brief characterization of the CULTEX® Radial Flow System
exposuredevice,whichallowsthe exposureofcultivatedcells
as well as bacteria under reproducible and stable conditions
for studying cellular and genotoxic effects after the exposure
at the air–liquid or air–agar interface, respectively. A
commercial bronchial epithelial cell line (16HBE14o-) as
well as Salmonella typhimurium tester strains were exposed
to smoke of different research and commercial available
cigarettes. A dose-dependent reduction of cell viability was
found in the case of 16HBE14o- cells; S. typhimurium
responded with a dose-dependent induction of revertants.
The promising results recommend the integration of cellular
studies in the field of inhalation toxicology and their regula-
tory acceptance by advancing appropriate validation studies.




The respiratory tract is the main entry for ambient air
pollutants like gases, volatile compounds, or particles.
Accordingly, acute cyto- and genotoxic effects as well as
chronic alterations, ranging from reversible cellular changes
to persistent modifications of the airways, are the major
effects on human health. Due to the fact that the incidence
of lung disease is also increasing [1, 2] as a major cause of
lethality, the studies in the field of inhalation toxicology
concentrate on the understanding of mechanisms of lung
injury and repair as well as the toxicological characteristics
and potency of inhalable substances. Usually, these adverse
biological effects are studied in animal experiments, but the
European Guideline Registration, Evaluation and Authori-
zation of Chemicals (REACH) demands the reduction and
replacement of animal experiments for logistical and ethical
reasons. Thus, there is an urgent need to develop, establish,
and validate alternative test methods as well as new
relevant test strategies to analyze airborne material. In the
case of inhalable material, there are challenges concerning
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In order to use such alternative systems of the respiratory
tract for studying the effect of airborne compounds like
gases, particles, or complex aerosols like cigarette smoke or
diesel exhaust, special devices for direct exposure of
cultivated cells or bacteria were established [3–9]. The idea
of Tarkington et al. [10] to guide the atmosphere via a
vertical dynamic stream directly to the biphasic cultivated
test organisms, was optimized in a new exposure system
called CULTEX® Radial Flow System (RFS).
The basic considerations for such a direct exposure
system mimicking the inhalation cycle in vivo are: (a)
relevant cell or test models, (b) cultivation of the biological
systems at the air–liquid interface (ALI), (c) direct contact
between the test organisms and airborne material, in the
case of cultivated cells without interfering medium and (d)
uniform exposure with the test material. The exposure can
be conducted directly under dynamic conditions, meaning
the continuous generation and transport of the test
atmosphere to the cells or bacteria, a directed aerosol
stream to the surface of the test organisms, a homogeneous
exposure as well as a reproducible deposition of particles,
and the continuous removal of the atmosphere.
Ideally, human cells of the respiratory tract should be
analyzed for cytotoxic and genotoxic investigations to
avoid species-specific discussion concerning the relevance
of the estimated effects. A variety of commercial cell lines
like A549, BEAS-2B, Calu-3, and 16HBE140- as well as
primary epithelial cells (e.g., NHBE cells, Lonza Group
Ltd., Switzerland; HBEpC, PromoCell GmbH, Germany)
are also available in addition to ready-to-use cell culture
systems (EpiAirway™, MatTek Corporation; MucilAir™,
Epithelix Sàrl) and can be used, for example, in screening
and drug absorption studies [11–17]. Furthermore, multi-
layered systems and tissue equivalents composed of
different cell populations (e.g., fibroblasts, macrophages,
and endothelial cells in combination with epithelial cells)
are described, which are suitable for more sophisticated
studies [18–24].
Bacterial systems can also be included in studies
investigating the genotoxic potency of airborne material in
the Ames assay by using strains of Salmonella typhimurium
and Escherichia coli. A miniaturization of the Ames assay
in agreement with the OECD guideline 471 allows the
estimation of a dose-related induction of revertants after
exposure of the bacteria at the air–agar interface [25, 26].
The exposure technique itself involves (1) the adjusted
generation of the test atmosphere, (2) the exposure process,
and (3) the analysis of the biological reactions of the test
organisms. The whole process must be controlled with
regard to medium supply of the cells, the flow rate of the
aerosol above the cells as well as the deposition rate of the
test atmosphere for calculating the exposure dose. By
taking into consideration all these aspects, it is possible to
create stable and reproducible experimental conditions
resulting in the estimation of dose–response relationships
for the actual test atmosphere. Examples of such studies
using cellular and bacterial test organisms exposed to
cigarette smoke are presented as well as the theoretical




For the generation of mainstream cigarette smoke, a varying
number (one to eight cigarettes) of K3R4F (9.4 mg tar/
cigarette) and K1R5F (1.67 mg tar/cigarette) cigarettes
(University of Kentucky Tobacco and Health Research
Institute in Lexington, KY, USA) were smoked on a smoke
robot according to ISO 3308 guidelines (35 ml puff volume,
2 s duration, one puff/min) for exposing 16HBE140- cells at
the air–liquid interface. To study the genotoxic potency of
cigarette smoke, the list of cigarettes was extended by a
monitorcigarette CM5(15mgtar/cigarette)anda commercial
brand with a tar content of 7 mg tar/cigarette (code: C1). The
freshly generated smoke was diluted with a constant flow of
synthetic air (0.5 and 1.0 l/min) in a mixing chamber
controlled by mass flow controllers. In this way, the
discontinuously generated smoke was diluted and converted
into a continuous aerosol flow (cell exposure, flow rate of
5 ml/min and exposure of bacteria, 10 ml/min) which was
sucked via negative pressure from a vacuum pump through
the CULTEX® RFS module shown in Fig. 1 (CULTEX®
Laboratories, Hannover, Germany).
The flow rates for each position within the module were
controlled separately by flow controllers to guarantee a
homogeneous gas stream and particle deposition over the
exposure positions. During the intervals of puff generation,
the test organisms were exposed to synthetic air. The
physical forces driving deposition of airborne material are:
(1) sedimentation, (2) diffusion, (3) electrical forces, and
(4) inertial impaction when using a very small flow through
the module to avoid an evaporation of the cells. The
theoretical consideration forming the basis of the efficiency
of the system can be found in the Electronic Supplementary
Material (ESM).
Bacterial strains and culture conditions
The genotoxic potency of cigarette smoke was analyzed with
the Ames assay by using the tester strains S. typhimurium TA
98 (frame-shift mutation) for whole cigarette smoke and
3214 M. Aufderheide et al.strainS. typhimurium TA 100 (missense mutation) for the gas
vapor phase (University of California, Berkeley, USA).
Single colonies were isolated and strain characteristics were
checked according to Maron and Ames [27]. A frozen
bacterial stock suspension was grown overnight at 37 °C in a
shaking incubator in 20 ml nutrient broth. Bacteria were in
the late log phase when used. To calculate the bacterial
number before seeding them onto the agar, aliquots of the
bacterial suspension were counted using an automated cell
counter and analyzer system (CASY Modell TT, Schärfe
System GmbH, Reutlingen, Germany). The bacteria were
seeded in Petri dishes of minimized scale (35 mm in
diameter, Nunc #150318) with and without overlay agar
(spread culture) [25, 26].
Mutagenicity assay
The overlay agar Method was consistent with the method
published by Maron and Ames [27]. Using the spread culture
method [28], the bacteria were poured directly onto the
selective agar plates (composition: 1.5% agar, 2% glucose,
Vogel/Bonner medium) already complemented with a histi-
dine/biotin solution (0.5 mM). Concurrent negative and
positive controls (according to OECD guideline 471) were
performed in all experiments testing solvent substances. To
show the mutagenic capacity of strains TA98 under
conventional conditions, positive control substances (the
directly acting mutagen 2-nitrofluorene and the indirectly
acting mutagen 2-amino-anthracene) were used. DMSO
served as negative control. In the case of direct exposure,
synthetic air (20.5% O2 in N2) was used as a negative control
whereas NO2, delivered from gas flasks (Messer-Griesheim,
Krefeld, Germany), was used as a positive control gas to
induce mutagenic effects. Different concentrations were ob-
tained by mixing with synthetic air, controlled by rotameters.
All testing was done using triplicate plates for each
dosage and experiments were repeated three times. After
exposure, the plates were incubated at 37 °C for 48–72 h.
For metabolic activation, the S9 fraction was obtained from
the Cytotest Cell Research GmbH (Rossdorf, Germany),
prepared from phenobarbital/naphthoflavone-induced rat
liver (Wistar) and stored in liquid nitrogen until use. The
metabolic activation system consisted of 16.7 ml PBS
(0.2 M, pH 7.4), 0.4 ml potassium chloride (1.65 M) and
magnesium chloride (0.4 M), 0.1 ml glucose-6-phosphate
(1 M), 0.8 ml NADP (0.1 M), and 2.0 ml S9 fraction. All
experiments with mainstream smoke were conducted with
S9 mix whereas all gas vapor phase (GVP) experiments
were performed without S9 mix.
ThedatawerecountedautomaticallywiththePROTOCOL-
Counter (Synbiosys, Cambridge, UK). The smoke was
considered to be toxic when reduced growth of the bacteria
(smaller number and/or smaller colonies) on the selective agar
plates occurred, or when a reduced background lawn was
observed.
In the Ames assay, a strain was defined as sensitive if
there was a reproducible demonstration of concentration-
related effects with a 2-fold increase in the number of
revertants over the spontaneous frequency of revertants. If
the number of revertants was below ten, at least 3-fold
increase of revertants was required. In addition, the
background lawn should be close to the nontoxic concen-
tration and the number of revertants should be within
accepted ranges [29].
Human bronchial epithelial cell line
The human bronchial epithelial cell line (16HBE14o-) cells
(Professor Gruenert, University of California, San Francisco,
USA) are immortalized human bronchial epithelial cells
(simian virus 40) that form polarized cell layers with intact
tight junctions and feature many characteristics of primary
Fig. 1 The modularly designed CULTEX® Radial Flow System is
composed of four basic components: the aerosol guiding module, the
sampling module, the socket module, and the locking module. The
construction allows comfortable handling and loading of the system
with the cell culture inserts. The insertion of adapters for cell culture
inserts of different size and manufacturers make the system very
flexible
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to differentiate into ciliated cells. The 16HBE14o- cells were
cultivated in cell culture flasks and microporous insert
membranes coated with a mixture containing collagen type
I and human fibronectin. As general growth medium, MEM
with Earle’s salts (including stable L-glutamine; Biochrom
FG 0325) supplemented with 10% fetal calf serum and
penicillin/streptomycin was used. The seeding density,
subculturing time point and the growth area of culture
vessels were each adapted to the requirements of the
experiments. In general, an overgrowth was avoided.
WST assay
The Cell Proliferation Reagent WST-1 (Roche Diagnostics
GmbH) is a nonradioactive, ready-to-use substrate which
measuresthemetabolicactivityofviablecells.Itissuitablefor
measuring cell proliferation, cell viability or cytotoxicity. The
assay is based on the reduction of WST-1 by viable cells. The
reaction produces a soluble formazan salt. The amount of
formazan, which is proportional to the mitochondrial activity
of the cells, is quantified by measuring the light absorbance at
450 nm.
In order to analyze the mitochondrial activity of cigarette
smoke-exposed cells, 550 μL of WST-1 reaction solution
(500 μL cell culture medium+50 μLWST-1) was added on
the surface of the cells. After 1-h incubation at 37 °C/5%
CO2, 100 μL solution was taken out of each well, pipetted
into a 96-well plate and read out at 450 nm.
Results
Acute cytotoxicity
In a series of experiments, the CULTEX® RFS was applied to
investigate acute cytotoxicity of whole mainstream cigarette
smoke on human bronchial epithelial cells (16HBE14o-) after
direct exposure at the ALI. The immortalized cell line is
characterized by functional tight junctions and an active ion
transport. The cells were grown on microporous membranes
(growth area of the insert vessel, 1 cm²) and exposed to
mainstream smoke of various numbers (one to eight ciga-
rettes) of Kentucky research cigarettes K3R4F (9.4 mg tar/
cigarette) and K1R5F (1.67 mg tar/cigarette). In parallel to
smoke exposure, another set of cells were exposed toclean air
in order to exclude damaging effects due to the methodical
setup (clean air control) or remained, as a second control
(incubator air-lifted culture) in the incubator and were
analyzed simultaneously to the exposed cells. 9.48% (w/w)
of the incoming smoke particles were deposited on filters
(SD, ±0.33%) placed in the inserts, thus pointing to a
homogeneous, stable and reproducible particle exposure.
After a post-incubation time of 24 h at 5% CO2/37 °C,
the cells were investigated for cell viability (WST-1 assay)
and the data of the smoke-exposed cells were normalized to
the values of the clean air control for each time point. In
Fig. 2a, the results of the exposure experiments show a
clear dose–response relationship for the high-tar cigarette.
No cytotoxic effect was found after exposure to mainstream
smoke of one cigarette. By increasing the number of
cigarettes, cell viability decreased. The exposure of eight
cigarettes induced an almost complete loss of cell viability.
The values of the incubator-control cells were comparable
to those exposed to clean air at each time point (data not
shown) and were, thus, considered no further. The exposure
of the cells to the low-tar cigarette revealed no sign of
toxicity if the cells were exposed to the smoke of up to ten
cigarettes. Cytotoxic effects are primarily visible after
Fig. 2 A Cell viability of undifferentiated 16HBE14o- cells after the
exposure to mainstream smoke of increasing numbers of Kentucky
research cigarettes K3R4F and K1R5F. The cell viability was
measured 24 h after the exposure performing the WST-1 assay and
normalized to the viability of clean-air-exposed cells. The values are
given as mean of three replicates + standard deviation. B Dose–
response curve for 16HBE14o-cells after the exposure to mainstream
smoke of increasing numbers of Kentucky research cigarettes K3R4F
and K1R5F and 24-h post-incubation. The curve was calculated from
the data achieved by the WST-1 assay. The calculation was performed
using the software Curve Expert 1.4
3216 M. Aufderheide et al.exposure to the smoke of 12 and more cigarettes. On the
basis of these data, dose–response curves (Fig. 2b) and
values for the effective dose were calculated for each
cigarette type (K3R4F: ED10: 2.48 cigarettes, ED50: 4.63
cigarettes; K1R5F: ED10: 7.79 cigarettes, ED50 32.37
cigarettes) by nonlinear regression software Curve Expert
1.4 (Harris Model) with a correlation coefficient of 0.995
and 0.97, respectively. Accordingly, the different cytotoxic
potentials of both cigarettes became apparent.
Other markers reflecting exposure-related cell damage
like oxidative stress, DNA damage, cytoskeletal changes or
immunomodulation can also be analyzed in a comparable
way
Genotoxicity—Ames assay
To analyze the genotoxic potency of complex mixtures like
whole smoke (WS), the CULTEX®RFS module can also be
adapted to expose S. typhimurium tester strains in a
modified Ames assay at the air–agar interface [25, 26].
The exposure of bacteria to synthetic air up to 1 h did not
change the number of induced revertants in comparison to the
spontaneous revertants, which were in the same range.
S. typhimurium strains TA98 and TA100 were exposed at
the air–agar interface with mainstream smoke or the filtered
smoke of the different cigarette brands to analyze the
discriminatory power of the method. The mutagenicity of
cigarettes was determined dependent on their tar content.
TA98 detected mutagenicity of whole smoke of all analyzed
brands in a dose-dependent manner (Fig. 3a). Mutagenicity
increased by increasing the tar content of the cigarettes
except in the monitor cigarette CM5 (15 mg tar/cigarettes)
which revealed a mutagenic activity below that of brand C1
with 7 mg tar/cigarette. K3R4F (9.4 mg tar/cigarette)
showed the highest mutagenicity, followed by brand C1
(7 mg tar/cigarette), CM5 (15 mg tar/cigarette) and K1R5F
(1.67 mg tar/cigarette).
The GVP was analyzed with strain TA100 (Fig. 3b).
Mutagenicity increased with rising tar content of the
cigarettes. The highest mutagenicity was detected with
brand C1 followed by brands CM5, K3R4F, and K1R5F.
The different activities of mainstream smoke and the gas
vapor phase demonstrated that the tar content alone cannot
explainthemutagenicactivityofacigarette,butratherthatthe
composition of the tar or modifications of the cigarette (filter




on 1st July 2007, boosting the protection of consumers and
animals. Due to the fact that 86% of the safety testing data for
existing chemicals are lacking [30, 31], the EU legislation
urged to list such data for chemicals produced or marketed in
quantities of more than 1 t per year [32–36]. Several attempts
were made to calculate the financial and experimental
investments, especially with regard to animal numbers
required [33–36]. Taking into the consideration the missing
information in the field of acute inhalation toxicology [33,
35, 37] and the demand of the new legislation to use
alternative methods, it became obvious that there will be a
demand for in vitro test systems for toxicological screening
comprising acute cytotoxic or genotoxic effects. Although in
vitro inhalation tests cannot replace animal testing complete-
ly at present, the availability of such test systems may
significantly reduce the number of animal experiments. For
instance, the in vitro data can provide further crucial
Fig. 3 Induction of revertants in A S. typhimurium strain TA98 after
exposure of the bacteria with diluted mainstream smoke and B in S.
typhimurium strain TA100 after exposure with diluted filtered smoke
(gas vapor phase) of cigarettes with different tar content (K3R4F:
9.5 mg tar/cigarette, K1R5F: 1.67 mg tar/cigarette, CM5: 15 mg tar/
cigarette, C1 7 mg tar/cigarette). “0 cigarettes” indicate synthetic air
control. The values are given as mean of three replicates + standard
deviation. Dilution: 1.0 l/min with synthethic air; flow rate through the
chambers: 10 ml/min
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tested substances from animal tests. Besides the reduction in
the number of animal experiments the use of in vitro
methods provides more basic benefits [38]. The space
required is negligibly small, and furthermore it is much
more time- and cost effective than traditional animal tests.
The use of in vitro methods in the field of inhalation
toxicology exhibits some special features especially
concerning technical equipment and exposure procedures.
Simulating the in vivo situation, target cells of the respiratory
tract (bronchial epithelial cells, alveolar cells) are exposed
directly at the air-liquid interface, meaning that the cultivated
cells are in direct contact with the inhalable compounds.
Specially designed exposure devices have been used success-
fully in studying such actual atmospheres [3, 4, 39–43]. Our
latest development, the CULTEX® RFS module, is charac-
terized by a radial distribution of the test atmosphere from
one sampling point to the cells, resulting in a homogeneous
deposition of particulate matter on the cells which can be
calculated according to a simplified model distinguishing
between sedimentation, differentiation and electrical deposi-
tion (Fig. S1 in the ESM).
The efficiency in providing a close contact between cells
and particles allows the analysis of dose–response relation-
ships. In our experiments, we exposed a human bronchial
epithelial cell line (16HBE14o-) to cigarette smoke generated
from the research cigarettes K1R5F and K3R4F, which differ
considerably in their tar content. The exposure of the cells to
increasing numbers of the corresponding cigarettes resulted in
a decrease of cell viability. The calculated dose–response
curves and key values (ED50)f o rad i r e c tc o m p a r i s o no fb o t h
cigarettes revealed their different cytotoxic potency. The
most common assessment of cigarette smoke cytotoxicity is
based on the evaluation of condensates and extracts of the
gas vapor phase [44, 45] also resulting in dose response
relationships, although the test material did not reflect the
composition of the native test atmosphere, e.g., with regard
to short living radicals and gaseous compounds. Also
interactions with medium components have to be taken in
consideration, distorting the biological effects. Accordingly,
the direct exposure method of cultivated cells at the air-liquid
interface is recommended for analyzing airborne material in
simulation to the in vivo situation [7, 18] .T h ee f f i c i e n c yo f
the method with regard to stability and reproducibility and
their relevance to be applied to reducing numbers of
experimental animals in the field of inhalation toxicology
have to be proven in validation studies. At the moment, a
prevalidation study on the CULTEX® method meaning direct
exposure of cultivated cells at the air-liquid interface with
special emphasis on particulate matter is under way (BMBF
project 0315710A).
Another approach used is the direct exposure strategy for
exposing bacteria at the air-agar interface in a modified
Ames assay [25, 26] to analyze the mutagenic potency of
cigarette smoke. The “Bacterial Reverse Mutation Assay” is
generally accepted (OECD 471) and has been widely used for
soluble compounds, condensates and extracts of complex
mixtures by combining test substances and bacteria within the
overlayagar.Themethodologicalapproachesforinvestigating
volatile compounds, gases or complex native mixtures
followed another strategy [25, 26, 28, 46, 47]. In accordance
with the method described by Araki et al. [28], we plated the
bacteria directly on the surface of selective agar (spread-
culture method) and exposed them to a continuous stream of
native whole (WS) and filtered cigarette smoke (GVP) of
four cigarettes (K3R4F, C1, CM5, K1R5F) with different tar
content (ranging from 1.67 to 15 mg per cigarette). The
experiments resulted in a dose-dependent (number of
cigarettes smoked) induction of revertants for both test
atmospheres (Fig. 3a, b). The discriminating capacity of the
modified Ames assay, known from studies with cigarette
condensates [44] could also be demonstrated for filtered and
unfiltered native mainstream cigarette smoke. In summary,
these studies showed that the mutagenic signals of native test
atmospheres,composedofparticulateandgaseouscompounds,
can be determined by direct exposure methods as well as to
differentiate between the mutagenicity of whole smoke and its
gas phase in a dose-dependent manner. Qualitative and
quantitative differences between complex atmospheres can be
discriminated according to their mutagenic activity.
The possibility to test native harmful atmospheres for the
screening of chemicals, industrial products as well as
complex atmospheres constitutes an interesting domain in
the context of acute toxicity and biological activities. The
application of direct exposure methods to analyze the
biological effects of inhalable substances offers new ways
to establish dose–response relationships of such substances
by simulating the in vivo situation. The challenge of such
studies is the multidisciplinary approach combining biolog-
ical and technical as well as aerosol physical aspects in
such a cell-based approach.
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